D. Andrew James

Dr. D. Andrew James

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2021 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
SZShaolong Zhu
Shaolong Zhu
PLPeter Liuni
Peter Liuni
TCTricia Chen
Tricia Chen
CHCamille Houy
Camille Houy
DWDerek Wilson
Derek Wilson
DJD. Andrew James
D. Andrew James

1 April 2021 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Open access
DNDominic Narang
Dominic Narang
DJD. Andrew James
D. Andrew James
MBMatthew T. Balmer
Matthew T. Balmer
DWDerek Wilson
Derek Wilson
The novel severe respiratory syndrome-like coronavirus (SARS-CoV-2) causes COVID-19 in humans and is responsible for one of the most destructive pandemics of the last century. At the root of SARS-CoV infection is the interaction between the viral spike protein and the human angiotensin converting enzyme 2 protein, which allows the virus to gain entry into host cells through endocytosis. In this work, we apply hydrogen–deuterium exchange mass spectrometry (HDX-MS) to provide a detailed view of the functional footprint and conformational dynamics associated with this interaction. Our results broadly agree with the binding interface derived from high resolution X-ray crystal structure data but also provide insights into shifts in structure and dynamics that accompany complexation, including some that occur immediately outside of the core binding interface. We propose that dampening of these “binding-site adjacent” dynamic shifts could represent a mechanism for neutralizing activity in a multitude of spike protein-targeted mAbs that have been found to specifically bind these “peripheral” sites. Our results highlight the unique capacity of HDX-MS to detect potential neutralization “hotspots” outside of the core binding interfaces defined by high resolution structural data.

18 December 2018 in Biochemistry
Verified
Journal Article
Closed access
SZShaolong Zhu
Shaolong Zhu
PLPeter Liuni
Peter Liuni
LELuciano Ettorre
Luciano Ettorre
TCTricia Chen
Tricia Chen
JSJason Szeto
Jason Szeto
DWDerek Wilson
Derek Wilson

5 August 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
SASalvador F. Ausar
Salvador F. Ausar
SZShaolong Zhu
Shaolong Zhu
JDJessica Duprez
Jessica Duprez
MCMichael Cohen
Michael Cohen
TBThomas Bertrand
Thomas Bertrand
DJD. Andrew James
D. Andrew James
The mutant gdPT R9K/E129G is a genetically detoxified variant of the pertussis toxin (PTx) and represents an attractive candidate for the development of improved pertussis vaccines. The impact of the mutations on the overall protein structure and its immunogenicity has remained elusive. Here we present the crystal structure of gdPT and show that it is nearly identical to that of PTx. Hydrogen-deuterium exchange mass spectrometry revealed dynamic changes in the catalytic domain that directly impacted NAD+ binding which was confirmed by biolayer interferometry. Distal changes in dynamics were also detected in S2-S5 subunit interactions resulting in tighter packing of B-oligomer corresponding to increased thermal stability. Finally, antigen stimulation of human whole blood, analyzed by a previously unreported mass cytometry assay, indicated broader immunogenicity of gdPT compared to pertussis toxoid. These findings establish a direct link between the conserved structure of gdPT and its ability to generate a robust immune response.

1 September 2020 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
LSLisa Szymkowicz
Lisa Szymkowicz
DWDerek Wilson
Derek Wilson
DJD. Andrew James
D. Andrew James

31 August 2018 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
DJD. Andrew James
D. Andrew James
MFManon J. Fradin
Manon J. Fradin
APArtur Pedyczak
Artur Pedyczak
BCBruce W. Carpick
Bruce W. Carpick